Cataract Risk Elevated in Pneumoconiosis - Top-Institutions - MDSpire

Cataract Risk Elevated in Pneumoconiosis

Researchers assess whether occupational lung disease is linked to long-term eye outcomes.

  • By

  • Kathryn Wighton

  • February 3, 2026

  • 3 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Pulmonary Medicine
    • Epidemiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Ophthalmology
    • Pulmonary Medicine
    • Occupational Medicine

  • #3

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Pulmonary Medicine
    • Epidemiology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Pulmonary Medicine
    • Occupational Health

  • #5

    National Institute of Environmental Health Sciences (NIEHS)
    National Institute of Environmental Health Sciences (NIEHS)

    Research Triangle Park, NC

    Key Differentiators

    • Environmental Health
    • Occupational Medicine
    • Epidemiology

Original Source(s)

Cataract Risk Elevated in Pneumoconiosis

  • by Kathryn Wighton

  • February 3, 2026

Related Content

Pulmonary surveillance in inborn errors of immunity: current challenges and emerging approaches

Preexisting Risk Drove Poststorm Events

Analysis of nearly 1.6 million veterans showed preexisting community health inequities largely explained poststorm cardiovascular and respiratory outcomes.

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.